Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Antibody Drug Conjugate Therapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Antibody Drug Conjugate Therapeuticsmarket, defines the market attractiveness level of Antibody Drug Conjugate Therapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Antibody Drug Conjugate Therapeutics industry, describes the types of Antibody Drug Conjugate Therapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Antibody Drug Conjugate Therapeutics market and the development prospects and opportunities of Antibody Drug Conjugate Therapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Antibody Drug Conjugate Therapeutics market in Chapter 13.
By Player:
Sanofi
Eli Lilly
Hoffman-Le Roche
Genentech
ImmunoGen
Genmab
Seattle Genetics
Novartis
Amgen
Synthon Holding
Bayer AG
Pfizer
By Type:
Mmunomedics Technology
Immunogen Technology
Genentech Technology
Others
By End-User:
Lymphoma
Leukemia
Multiple Myeloma
Skin Cancer
Colon Cancer
Glioblastoma
Pancreatic Cancer
Prostate Cancer
Solid Tumor
Breast Cancer
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Antibody Drug Conjugate Therapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Antibody Drug Conjugate Therapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Antibody Drug Conjugate Therapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Antibody Drug Conjugate Therapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Antibody Drug Conjugate Therapeutics Market Analysis and Outlook to 2022
-
7.1 Global Antibody Drug Conjugate Therapeutics Consumption (2017-2022)
-
7.2 United States Antibody Drug Conjugate Therapeutics Consumption (2017-2022)
-
7.3 Europe Antibody Drug Conjugate Therapeutics Consumption (2017-2022)
-
7.4 China Antibody Drug Conjugate Therapeutics Consumption (2017-2022)
-
7.5 Japan Antibody Drug Conjugate Therapeutics Consumption (2017-2022)
-
7.6 India Antibody Drug Conjugate Therapeutics Consumption (2017-2022)
-
7.7 South Korea Antibody Drug Conjugate Therapeutics Consumption (2017-2022)
8 Region and Country-wise Antibody Drug Conjugate Therapeutics Market Analysis and Outlook to 2028
-
8.1 Global Antibody Drug Conjugate Therapeutics Consumption Forecast (2022-2028)
-
8.2 United States Antibody Drug Conjugate Therapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Antibody Drug Conjugate Therapeutics Consumption Forecast (2022-2028)
-
8.4 China Antibody Drug Conjugate Therapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Antibody Drug Conjugate Therapeutics Consumption Forecast (2022-2028)
-
8.6 India Antibody Drug Conjugate Therapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Antibody Drug Conjugate Therapeutics Consumption Forecast (2022-2028)
9 Global Antibody Drug Conjugate Therapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Antibody Drug Conjugate Therapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Mmunomedics Technology Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immunogen Technology Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Genentech Technology Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Antibody Drug Conjugate Therapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Lymphoma Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Leukemia Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Skin Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Colon Cancer Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Glioblastoma Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Pancreatic Cancer Consumption and Growth Rate (2017-2022)
-
9.2.8 Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
9.2.9 Global Solid Tumor Consumption and Growth Rate (2017-2022)
-
9.2.10 Global Breast Cancer Consumption and Growth Rate (2017-2022)
10 Global Antibody Drug Conjugate Therapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Antibody Drug Conjugate Therapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Mmunomedics Technology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immunogen Technology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Genentech Technology Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Antibody Drug Conjugate Therapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Colon Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Glioblastoma Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Pancreatic Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.8 Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.9 Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
10.2.10 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
11 Global Antibody Drug Conjugate Therapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Antibody Drug Conjugate Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Antibody Drug Conjugate Therapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Antibody Drug Conjugate Therapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Antibody Drug Conjugate Therapeutics Market Competitive Analysis
-
14.1 Sanofi
-
14.1.1 Sanofi Company Details
-
14.1.2 Sanofi Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Sanofi Antibody Drug Conjugate Therapeutics Product and Service
-
14.2 Eli Lilly
-
14.2.1 Eli Lilly Company Details
-
14.2.2 Eli Lilly Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Eli Lilly Antibody Drug Conjugate Therapeutics Product and Service
-
14.3 Hoffman-Le Roche
-
14.3.1 Hoffman-Le Roche Company Details
-
14.3.2 Hoffman-Le Roche Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Hoffman-Le Roche Antibody Drug Conjugate Therapeutics Product and Service
-
14.4 Genentech
-
14.4.1 Genentech Company Details
-
14.4.2 Genentech Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Genentech Antibody Drug Conjugate Therapeutics Product and Service
-
14.5 ImmunoGen
-
14.5.1 ImmunoGen Company Details
-
14.5.2 ImmunoGen Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 ImmunoGen Antibody Drug Conjugate Therapeutics Product and Service
-
14.6 Genmab
-
14.6.1 Genmab Company Details
-
14.6.2 Genmab Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Genmab Antibody Drug Conjugate Therapeutics Product and Service
-
14.7 Seattle Genetics
-
14.7.1 Seattle Genetics Company Details
-
14.7.2 Seattle Genetics Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Seattle Genetics Antibody Drug Conjugate Therapeutics Product and Service
-
14.8 Novartis
-
14.8.1 Novartis Company Details
-
14.8.2 Novartis Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novartis Antibody Drug Conjugate Therapeutics Product and Service
-
14.9 Amgen
-
14.9.1 Amgen Company Details
-
14.9.2 Amgen Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Amgen Antibody Drug Conjugate Therapeutics Product and Service
-
14.10 Synthon Holding
-
14.10.1 Synthon Holding Company Details
-
14.10.2 Synthon Holding Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Synthon Holding Antibody Drug Conjugate Therapeutics Product and Service
-
14.11 Bayer AG
-
14.11.1 Bayer AG Company Details
-
14.11.2 Bayer AG Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Bayer AG Antibody Drug Conjugate Therapeutics Product and Service
-
14.12 Pfizer
-
14.12.1 Pfizer Company Details
-
14.12.2 Pfizer Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Pfizer Antibody Drug Conjugate Therapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Antibody Drug Conjugate Therapeutics
-
Figure Antibody Drug Conjugate Therapeutics Picture
-
Table Global Antibody Drug Conjugate Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antibody Drug Conjugate Therapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Antibody Drug Conjugate Therapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Antibody Drug Conjugate Therapeutics Consumption by Country (2017-2022)
-
Figure United States Antibody Drug Conjugate Therapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Antibody Drug Conjugate Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Antibody Drug Conjugate Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Antibody Drug Conjugate Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Antibody Drug Conjugate Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Antibody Drug Conjugate Therapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Antibody Drug Conjugate Therapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Antibody Drug Conjugate Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Antibody Drug Conjugate Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Antibody Drug Conjugate Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Antibody Drug Conjugate Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Antibody Drug Conjugate Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Antibody Drug Conjugate Therapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mmunomedics Technology Consumption and Growth Rate (2017-2022)
-
Figure Global Immunogen Technology Consumption and Growth Rate (2017-2022)
-
Figure Global Genentech Technology Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Lymphoma Consumption and Growth Rate (2017-2022)
-
Figure Global Leukemia Consumption and Growth Rate (2017-2022)
-
Figure Global Multiple Myeloma Consumption and Growth Rate (2017-2022)
-
Figure Global Skin Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Colon Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Glioblastoma Consumption and Growth Rate (2017-2022)
-
Figure Global Pancreatic Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Prostate Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Tumor Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Mmunomedics Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunogen Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Genentech Technology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lymphoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Leukemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Multiple Myeloma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Skin Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Colon Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Glioblastoma Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pancreatic Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Prostate Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solid Tumor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Antibody Drug Conjugate Therapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Antibody Drug Conjugate Therapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Antibody Drug Conjugate Therapeutics Product and Service
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Antibody Drug Conjugate Therapeutics Product and Service
-
Table Hoffman-Le Roche (Foundation Year, Company Profile and etc.)
-
Table Hoffman-Le Roche Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffman-Le Roche Antibody Drug Conjugate Therapeutics Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Antibody Drug Conjugate Therapeutics Product and Service
-
Table ImmunoGen (Foundation Year, Company Profile and etc.)
-
Table ImmunoGen Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table ImmunoGen Antibody Drug Conjugate Therapeutics Product and Service
-
Table Genmab (Foundation Year, Company Profile and etc.)
-
Table Genmab Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genmab Antibody Drug Conjugate Therapeutics Product and Service
-
Table Seattle Genetics (Foundation Year, Company Profile and etc.)
-
Table Seattle Genetics Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Seattle Genetics Antibody Drug Conjugate Therapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Antibody Drug Conjugate Therapeutics Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Antibody Drug Conjugate Therapeutics Product and Service
-
Table Synthon Holding (Foundation Year, Company Profile and etc.)
-
Table Synthon Holding Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Synthon Holding Antibody Drug Conjugate Therapeutics Product and Service
-
Table Bayer AG (Foundation Year, Company Profile and etc.)
-
Table Bayer AG Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Antibody Drug Conjugate Therapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Antibody Drug Conjugate Therapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Antibody Drug Conjugate Therapeutics Product and Service
-
